Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sorrento Therapeutics Inc (NQ: SRNE ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sorrento Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 Next > Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients March 31, 2022 Via Benzinga The Biotech Company That's Training Immune Cells To Fight Cancer March 29, 2022 Photo by National Cancer Institute on Unsplash Dr. Henry Ji, President and CEO of Sorrento Therapeutics (NASDAQ: SRNE), was a guest speaker at Benzinga’s All Access on March 25, 2022. Via Benzinga 10 Biggest Price Target Changes For Friday March 25, 2022 Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. Via Benzinga Race to Develop Universal ‘Variant-Proof’ Covid Vaccine Involves Several Players March 24, 2022 FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2022 – USA News Group – Whenever a new COVID-19 variant emergences, health authorities have had limited options to fight... Via FinancialNewsMedia Exposures COVID-19 Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants March 21, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday February 23, 2022 On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Sorrento's COVID-19 Main Protease Inhibitor Neutralizes Omicron January 28, 2022 Sorrento Therapeutics Inc's (NASDAQ: SRNE) late-stage preclinical Mpro inhibitor, STI-1558, Via Benzinga The Week In SPAC News: Digital World Under Pressure As Truth Social Rank Slides March 20, 2022 In SPAC news this week, Digital World Acquisition was in the spotlight after Truth Social dropped out of the App Store's top 125. Meanwhile, Bridgetown 2 shareholders approved the previously announced... Via Talk Markets Sorrento's Pain Company Reveals Final Results For SP-102 Data For Sciatica Pain Management March 18, 2022 Sorrento Therapeutics Inc's (NASDAQ: SRNE) subsidiary Scilex Holding Company has announced final results from its SP-102 Phase 3 Pivotal Trial C.L.E.A.R. Program. SP-102 (Semdexa) has received Fast... Via Benzinga Vickers Venture SPAC To Merge With Sorrento Therapeutics' Pain-Focused Subsidiary March 18, 2022 Vickers Venture Partners' special purpose acquisition company Vickers Vantage Corp I (NASDAQ: VCKA) will merge with Scilex Holding Company, focused on developing and commercializing non-opioid... Via Benzinga Newman Ferrara LLP Announces Corporate Governance Investigation of Sorrento Therapeutics, Inc. – SRNE January 31, 2022 From Newman Ferrara LLP Via Business Wire Stocks That Hit 52-Week Lows On Tuesday March 08, 2022 Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a... Via Benzinga Stocks That Hit 52-Week Lows On Friday March 04, 2022 On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 31, 2022 Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday February 22, 2022 During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to... Via Benzinga Market Briefing For Wednesday, Jan. 26 January 26, 2022 The multiple U-turns Tuesday, instead of more consolidation just ahead of the Fed's decision, reflects the character of 'take no prisoners', buy the dips, and run for the hills. Via Talk Markets Introduction of Innovative PCR-Based Detection Methods Surges Fueled by Pandemic and Other Diseases February 18, 2022 Palm Beach, FL – February 18, 2022 – FinancialNewsMedia.com News Commentary – PCR testing and the COVID-19 diagnostic testing market has, unexpectantly, been growing at a substantial rate the past few... Via FinancialNewsMedia Topics Intellectual Property Exposures COVID-19 Intellectual Property The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective January 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kura Announces Lifting Of Clinical Hold On Phase 1 Blood Cancer Study Kura... Via Benzinga Sorrento Therapeutics' COVID-19 Antibody Works Against Omicron Variant January 20, 2022 Sorrento Therapeutics Inc (NASDAQ: SRNE) has released new data on STI-9167, an advanced stage antibody against COVID-19. The antibody was discovered and developed in an... Via Benzinga Stocks That Hit 52-Week Lows On Friday January 14, 2022 During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... Via Benzinga Market Briefing For Monday, Jan. 10 January 09, 2022 For the new week perhaps some consolidation and then an effort to improve the market's tone; especially as the small-caps should be entitled to bounce. Via Talk Markets Stocks That Hit 52-Week Lows On Thursday January 06, 2022 On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... Via Benzinga Stocks Hitting New 52-Week Lows Today January 03, 2022 On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... Via Benzinga NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today? December 29, 2021 NRx is seeking breakthrough designation for its treatment based on new, favorable data on the drug. NRXP stock is climbing on the news. Via InvestorPlace Market Briefing For Wednesday, Dec. 29 December 29, 2021 Concerns are still with the market and there are broad S&P assumptions about renewed upward behavior. Maybe, but it will be mixed. Via Talk Markets Market Briefing For Tuesday, Dec. 28 December 28, 2021 'Treacherous' is the term widely-applied to the coming dichotomy of 2022. It encompasses both the questions of 'living with' COVID and 'living with Fed monetary policy. Via Talk Markets PreMarket Prep Stock Of The Day: Sorrento Therapeutics December 27, 2021 This deep into the pandemic, positive vaccine or testing-related news doesn't always elicit the same type of reaction as in the early stages of the virus. A good... Via Benzinga Market Briefing For Thursday, Dec. 23 December 23, 2021 'Fortune favors the brave' it is said; it's partially so in this market, where we certainly got the ignition Tuesday of the seasonal rebound we looked for and more on Wednesday. Via Talk Markets Market Briefing For Wednesday, Dec. 22 December 22, 2021 Glimmers of hope are not 'yet' overwhelmed by monetary policy snugging, as the market 'for now' has tailwinds that justified buying recent speculations during purges. Via Talk Markets Market Briefing For Tuesday, Dec. 21 December 21, 2021 Snowstorms don't have to be blizzards. This market has recently been more akin to a 'ground blizzard', where snow is lifted, falling and more or less blowing around. Via Talk Markets < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.